Pacific Shuanglin Bio-pharmacy Co., Ltd. engages in the biochemical engineering, pharmaceutical industry equipment, and medical materials businesses in China. Its lead products include human serum albumin, human immunoglobulin, intravenous human immunoglobulin (PH4), human rabies immunoglobulin, hepatitis B human immunoglobulin, tetanus human immunoglobulin, tianqi analgesic cream, musk herd cream, musk bone paste, anti-inflammatory analgesic cream, dieshangling plasters, and medical gauzes. The company is also involved in the development of porcine pulmonary surfactants, shaqifang compounds, a1-protease inhibitors, human coagulation factor VIII products, and human fibrinogens. In addition, it engages in the investment, consultation, and technology promotion of pharmaceutical and biotechnology development projects; real estate development; and electronic product information consultation, as well as in the provision of electricity. The company was formerly known as Southern Shuanglin Bio-pharmacy Co., Ltd. and changed its name to Pacific Shuanglin Bio-pharmacy Co., Ltd. in April 2021. Pacific Shuanglin Bio-pharmacy Co., Ltd. is based in Taiyuan, China.
Pacific Shuanglin Bio-pharmacy Dividend Announcement
• Pacific Shuanglin Bio-pharmacy announced a annually dividend of ¥0.20 per ordinary share which will be made payable on 2024-06-28. Ex dividend date: 2024-06-28
• Pacific Shuanglin Bio-pharmacy annual dividend for 2024 was ¥0.20
• Pacific Shuanglin Bio-pharmacy annual dividend for 2023 was ¥0.08
• Pacific Shuanglin Bio-pharmacy 's trailing twelve-month (TTM) dividend yield is 0.94%
• Pacific Shuanglin Bio-pharmacy 's payout ratio for the trailing twelve months (TTM) is 19.11%
Pacific Shuanglin Bio-pharmacy Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-06-28 | ¥0.20 | annually | 2024-06-28 |
2023-07-20 | ¥0.08 | annually | 2023-07-20 |
2022-07-15 | ¥0.06 | annually | 2022-07-15 |
2020-07-27 | ¥0.23 | annually | 2020-07-27 |
Pacific Shuanglin Bio-pharmacy Dividend per year
Pacific Shuanglin Bio-pharmacy Dividend growth
Pacific Shuanglin Bio-pharmacy Dividend Yield
Pacific Shuanglin Bio-pharmacy current trailing twelve-month (TTM) dividend yield is 0.94%. Interested in purchasing Pacific Shuanglin Bio-pharmacy stock? Use our calculator to estimate your expected dividend yield:
Pacific Shuanglin Bio-pharmacy Financial Ratios
Pacific Shuanglin Bio-pharmacy Dividend FAQ
Other factors to consider when evaluating Pacific Shuanglin Bio-pharmacy as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Pacific Shuanglin Bio-pharmacy stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Pacific Shuanglin Bio-pharmacy 's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Pacific Shuanglin Bio-pharmacy publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Pacific Shuanglin Bio-pharmacy distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Pacific Shuanglin Bio-pharmacy are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Pacific Shuanglin Bio-pharmacy sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Pacific Shuanglin Bio-pharmacy distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Pacific Shuanglin Bio-pharmacy declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Pacific Shuanglin Bio-pharmacy 's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Pacific Shuanglin Bio-pharmacy 's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.